Progress in the development of histamine H3 receptor antagonists/inverse agonists: a patent review (2013-2017)

D Łażewska, K Kieć-Kononowicz - Expert opinion on therapeutic …, 2018 - Taylor & Francis
Introduction: Since years, ligands blocking histamine H3 receptor (H3R) activity
(antagonists/inverse agonists) are interesting targets in the search for new cures for CNS …
被引用次数：36 相关文章

[引用][C] Progress in the development of histamine H3 receptor antagonists/inverse agonists: a patent review (2013-2017)

D Łażewska, K Kieć-Kononowicz - Expert Opinion on Therapeutic …, 2018 - cir.nii.ac.jp
Progress in the development of histamine H<sub>3</sub> receptor antagonists/inverse
agonists: a patent review (2013-2017) | CiNii Research CiNii 国立情報学研究所 学術情報 …

Progress in the development of histamine H3 receptor antagonists/inverse agonists: a patent review (2013-2017)

D Łażewska… - Expert opinion on …, 2018 - pubmed.ncbi.nlm.nih.gov
Introduction Since years, ligands blocking histamine H 3 receptor (H 3 R) activity
(antagonists/inverse agonists) are interesting targets in the search for new cures for CNS …

[引用][C] Progress in the development of histamine H3 receptor antagonists/inverse agonists: a patent review (2013-2017)

D Łażewska, K Kieć-Kononowicz - Expert Opinion on Therapeutic …, 2018 - ruj.uj.edu.pl
Progress in the development of histamine H3 receptor antagonists/inverse agonists : a patent
review (2013-2017) Przejdź do treści Pomoc A A A Zmień kontrast Zaloguj English polski …

Progress in the development of histamine H3 receptor antagonists/inverse agonists: a patent review (2013-2017).

D Łażewska, K Kieć-Kononowicz - Expert Opinion on Therapeutic …, 2018 - europepmc.org
INTRODUCTION: Since years, ligands blocking histamine H3 receptor (H3R) activity
(antagonists/inverse agonists) are interesting targets in the search for new cures for CNS …